Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: Report of a series of cases

International Journal of Gynecological Pathology

Volumn 33, Issue 5, 2014, Pages 470-476

  Mansor, Sorsiah ^a   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Endometrioid adenocarcinoma; Immunohistochemistry; Ovary; Serous borderline tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CASE REPORT; CELL POPULATION; CLINICAL FEATURE; ENDOMETRIOSIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOSIS RATE; NEOPLASM; OVARIAN ENDOMETRIOID ADENOCARCINOMA; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; SEROUS BORDERLINE TUMOR; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PATHOLOGY;

TUMOR MARKER; VIMENTIN;

AGED; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84906046977     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0000000000000087     Document Type: Article

References (25)

1. McCluggage WG. Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis. Pathology 2011;43:420-32.
2. Seidman JD, Horkayne-Szakaly I, Haiba M, et al. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 2004; 23:41-4. (Pubitemid 38018236)
3. Kö bel M, Kalloger SE, Huntsman DG, et al. Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol 2010;29:203-11.
4. Snyder RR, Norris HJ, Tavassoli F. Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases. Am J Surg Pathol 1998;12:661-71.
5. Bell KA, Kurman RJ. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol 2000;24:1465-79.
6. Roth L, Emerson RE, Ulbright TM. Ovarian endometrioid tumors of low malignant potential: A clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma. Am J Surg Pathol 2003;27:1253-9. (Pubitemid 37040588)
7. McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol 2005;22:3-32. (Pubitemid 43163177)
8. Young RH, Scully RE. Differential diagnosis of ovarian tumors based primarily on their patterns and cell types. Semin Diagn Pathol 2001;18:161-235. (Pubitemid 32801085)
9. Young RH, Scully RE. Oxyphilic tumors of the male and female genital tracts. Semin Diagn Pathol 1999;16:146-61. (Pubitemid 29357972)
10. Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol 2004;23:200-5. (Pubitemid 38857108)
11. Soslow RA. Histologic subtypes of ovarian carcinoma: An overview. Int J Gynecol Pathol 2008;27:161-74. (Pubitemid 351450675)
12. Shih IM, Kurman RJ. Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004;164:1511-8. (Pubitemid 38529752)
13. Boger-Megiddo I, Weiss NS. Histologic subtypes and laterality of primary epithelial ovarian tumors. Gynecol Oncol 2005;97: 80-3. (Pubitemid 40403678)
14. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 2004;28: 496-504. (Pubitemid 38436523)
15. McCluggage WG. WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. Int J Gynecol Pathol 2004;23:97-9. (Pubitemid 38391767)
16. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 2000;19:158-63. (Pubitemid 30212153)
17. Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 2004;44:109-15. (Pubitemid 38296970)
18. Goldstein NS, Uzieblo A. WT-1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 2002;117:541-5. (Pubitemid 34823682)
19. Stewart CJ, Brennan BA, Chan T, et al. WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis. Pathology 2008;40:592-9.
20. Clement PB, Young RH. Surface epithelial-stromal tumors: Endometrioid, clear cell, transitional, squamous, rare, undifferentiated, and mixed cell types. Atlas of Gynecologic Surgical Pathology. China: Saunders Elsevier, Chapter 14; 2008:335.
21. Sangoi AR, Soslow RA, Teng NN, et al. Ovarian clear cell carcinoma with papillary features: A potential mimic of serous tumor of low malignant potential. Am J Surg Pathol 2008;32: 269-74. (Pubitemid 351172142)
22. Karnezis AN, Aysal A, Zaloudek CJ, et al. Transitional cell-like morphology in ovarian endometrioid carcinoma: Morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma. Am J Surg Pathol 2013;37:24-37.
23. Tornos C, Silva EG, Ordonez NG, et al. Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases. Am J Surg Pathol 1995;19:1343-53. (Pubitemid 3007343)
24. Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinicopathological analysis of 13 cases. Am J Surg Pathol 1982;6:513-22. (Pubitemid 12029443)
25. Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors. Sertoliform variant of endometrioid carcinoma. Cancer 1982;50:1322-31. (Pubitemid 12031956)